Clinical study of myoclonic epileptic syndromes

Authors

  • Nikhil Goli Senior Resident, Department of General Medicine, Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
  • Srikanth Koguru Senior Resident, Department of General Medicine, Malla Reddy Institute of Medical Sciences, Suraram, Hyderabad, Telangana, India
  • Rustom S. Wadia Consultant Neurologist of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India
  • Sanjay Agarwal HOD of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India
  • Pradeep Patel Resident of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India
  • Pradeep Reddy Resident of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India
  • Karthik Nallam Resident of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India
  • Datta Kharwade Resident of Internal Medicine, Ruby Hall Clinic, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20162187

Keywords:

Clinical study, Myoclonic, Syndrome

Abstract

Background: Incidence of different myoclonic epileptic syndromes is variable in different regions. Here in as there is very few literature available internationally being inclusive of all myoclonic epilepsies together. Very few studies are available which describe all characteristics in a given study population. The aim of the study was to find incidence of different types of myoclonic epilepsies among patients presenting with myoclonic seizures their characteristics and to study all myoclonic epilepsies and juvenile myoclonic epilepsy in the study population.

Methods: In this study conducted in neurological unit at Ruby hall clinic, a total of 188 case of epileptic disorder were enrolled irrespective of age and sex, among 136 were new case of epileptic disorder were classified based on seizure pattern, 23 were new cases of myoclonic epilepsy, these 23 new case of myoclonic epilepsy along with 52 old cases of myoclonic epilepsy attending to neurological unit were clubbed, a total of 75 cases myoclonic epilepsy were studied. All cases of myoclonic epilepsy and juvenile myoclonic epilepsy were studied with respect to age of onset different seizures, relation with family history, response to treatment, EEG findings.

Results: Out of 136 cases 23 were new cases of myoclonic epilepsy, these 23 newly diagnosed cases of myoclonic epilepsies along with 52 already diagnosed myoclonic epilepsy are clubbed together, total of 75 cases were further studied. Incidence of myoclonic epilepsy among epileptic patients found to be 16.9%. Incidence of JME among myoclonic epilepsies is 75-80%, in all myoclonic epilepsies and JME association with GTCS, family history, EEG abnormalities were common finding, valproate and leviteracetam are good therapeutic options, carbamazepine aggravated myoclonus.

Conclusions: For diagnosis of myoclonic epilepsy proper clinical history stress laid to ask history of myoclonic jerk in case of all seizure disorder, diagnosis basically depends on proper knowledge of myoclonic epileptic syndrome, eliciting history, EEG as an ancillary testing when in doubt always expert opinion is required as misdiagnosis of the myoclonus as partial seizure leads to wrong prescription of carbamazepine which exacerbates the myoclonus.

References

Hammond WH. On convulsive tremor. New York J Med. 1867;5(1):185-6.

Clark LP, Prout TP. Nature and pathology of Myoclonic epilepsy. Am J Insanity. 1903;60(1):291-306.

Hodskins MB, Yarkolev PJ. Anatomic-clinical observations on myoclonus in epileptics and on related symptom complexes. Am J Psychiatry. 1930;9(2):827-48.

Janeway R, JR Pearl LA, Sazeki. Progressive myoclonic epilepsies with lafora inclusion bodies clinical, genetic, histologic study. Arch Neurol. 1967;16(2):565-82.

Robert MD, Donald WM. Study on clinical significance and approach to classification of myoclonus. Arch Neurology. 1960;2(1):600-15.

John NC. Myoclonus: current concepts and recent advances. Lancet Neurology. 2004;3(10):598-607.

John NC, Alving LI, Maraganore DM. The incidence and prevalence of myoclonus in Olmsted county, minnesota. Mayo Clinic Proc. 1999;74(6):565-9.

Senanayake N. Classification of epileptic seizures, a hospital based survey of 1250 patients in a developing country. Epilepsia. 1993;34(5):812-8.

Sridharan R. Epidemiology of epilepsy. Current Sci. 2002;82(6):664-70.

KIeranen T, Sillapam, Riekkinen PJ. Distribution of seizure in epileptic population. Epilepsia. 1988;29(1):1-7.

Banerjee TK, Roy BK, Das SK, Hazra A, Chaudi A, Raut DK. A longitudinal study of epilepsy in Calcutta. Epilepsia. 2010;51(12):2384-91.

Mehndiratta MM, Aggarwal P. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy. Seizure. 2002;11(7):431-6.

Salas PJ, Tunon A, Vidal JA, Mateos V, Guisasola LM, Lahoz CH, Janz. Juvenile myoclonic epilepsy a little known frequent syndrome a study of 85 patients. Med Clinc. 1994;103(18):684-9.

Shahanaz, Sher K, Sattar RA. Clinical and EEG characteristics of JME. Pak J Medical Sci. 2014;1(2):12-5.

Ercegovac MD, Vojvodic N, Sokic DV, Jankovic SM, Drulovic J, Stojasavljevic N, Levic Z, Srp Arh Celok Lek. 1998 Sep-Oct; 126 (9): 335-344.

James W, Wheless, Sankar R. Treatment strategies for myoclonic seizures and epileptic syndromes with myoclonic seizure. Epilepsia. 2003;11(2):27-37.

Panayiotopoulos CP, Obeid T, Tahan AR. Juvenile myoclonic epilepsy. A 5 year prospective study. Epilepsia. 1994;35(2):285-96.

Shibasaki H, Yamshita Y, Kurowa Y. Electroencephalographic correlates in myoclonic Epilepsy. Brain J Neuro. 1978;101(3):447-60.

Jayalakshmi SS, Srinivasa RB, Sailaja S. Focal assymetries in EEG of JME. Acta Neurol Scand. 2010;122(2):115-23.

Downloads

Published

2016-12-29

Issue

Vol. 3 No. 3 (2016): July-September 2016

Section

Original Research Articles